Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Vicki Rousell"'
Autor:
Paloma Moraga, Paula Prieto, Almari Conradie, Majda Benhayoun, Vicki Rousell, Maria Davy, Uwe Fuhr, Rosa Antonijoan Arbos, Francisco Abad‐Santos, Antonio Portolés, Jolanda Van Duinen, Antonio J. Carcas, Alberto M. Borobia, the ERA4TB Consortium
Publikováno v:
Clinical and Translational Science, Vol 16, Iss 12, Pp 2421-2428 (2023)
Abstract First‐time‐in‐human (FTIH) trials are designed to generate information on the safety, tolerability, as well as the pharmacokinetic and pharmacodynamics profile of new drugs. To ensure the safety of participants, these trials need to be
Externí odkaz:
https://doaj.org/article/d614109e5d3743f585d46e379263ac7b
Autor:
Ann K. Miller, Andrew P. Beelen, Sushma Narayan, François Nosten, Germana Bancone, Supornchai Kongpatanakul, Jörg J. Möhrle, Ammar Qureshi, Ronnatrai Rueangweerayut, Nushara Yubon, Justin A. Green, Jörg-Peter Kleim, Emma J. Harrell, Vicki Rousell, Stephan Duparc, Khadeeja Mohamed, Lucio Luzzatto
Tafenoquine is an 8-aminoquinoline under investigation for the prevention of relapse in Plasmodium vivax malaria. This open-label, dose-escalation study assessed quantitatively the hemolytic risk with tafenoquine in female healthy volunteers heterozy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::abde1bc5cfbf1e968bc43e52268bcf02
https://doi.org/10.4269/ajtmh.16-0779
https://doi.org/10.4269/ajtmh.16-0779
Autor:
Ronnatrai, Rueangweerayut, Germana, Bancone, Emma J, Harrell, Andrew P, Beelen, Supornchai, Kongpatanakul, Jörg J, Möhrle, Vicki, Rousell, Khadeeja, Mohamed, Ammar, Qureshi, Sushma, Narayan, Nushara, Yubon, Ann, Miller, François H, Nosten, Lucio, Luzzatto, Stephan, Duparc, Jörg-Peter, Kleim, Justin A, Green
Publikováno v:
The American Journal of Tropical Medicine and Hygiene
Tafenoquine is an 8-aminoquinoline under investigation for the prevention of relapse in Plasmodium vivax malaria. This open-label, dose-escalation study assessed quantitatively the hemolytic risk with tafenoquine in female healthy volunteers heterozy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::71d3486e0aff71bfb9aa641dc9dd2076
https://pubmed.ncbi.nlm.nih.gov/28749773
https://pubmed.ncbi.nlm.nih.gov/28749773
Publikováno v:
D21. ASTHMA THERAPY: NEW TARGETS, NEW TRICKS.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::27d5a2314f784852102dae5c55e487e1
https://doi.org/10.1164/ajrccm-conference.2010.181.1_meetingabstracts.a5408
https://doi.org/10.1164/ajrccm-conference.2010.181.1_meetingabstracts.a5408
Autor:
Vicki Rousell, Friedrich Horak, René Zieglmayer, Petra Zieglmayer, Emma Salmon, Philippe Bareille
Publikováno v:
Current medical research and opinion. 24(6)
The Vienna Challenge Chamber (VCC) offers a controlled and controllable paradigm in which to reproducibly evaluate the efficacy of anti-allergic treatment. The aim of this study was to assess the efficacy of the novel intranasal corticosteroid flutic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::122b5fde1d3c6049078e48999e29c362
https://pubmed.ncbi.nlm.nih.gov/18498678
https://pubmed.ncbi.nlm.nih.gov/18498678
Autor:
Petra Zieglmayer, René Zieglmayer, Philippe Bareille, Vicki Rousell, Emma Salmon, Friedrich Horak
Publikováno v:
Current Medical Research & Opinion; Jun2008, Vol. 24 Issue 6, p1833-1840, 8p
Publikováno v:
Clinical Pharmacokinetics
Background Fluticasone furoate (FF; GW685698) is a novel inhaled corticosteroid that is active at 24 h and under development for once-daily administration in combination with the long-acting β2-adrenoceptor agonist vilanterol (GW642444) for chronic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1bd9ebd0bc7f624073e651c821813516